Other languages Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Real-time Estimate Cboe BZX Other stock markets 03:08:01 2024-04-30 pm EDT			5-day change	1st Jan Change
44.96 ^USD	-1.26%		+11.73%	+11.43%

Apr. 29	Soleno Therapeutics' Shares Jump After FDA Grants Breakthrough Designation for Prader-Willi Syndrome Treatment	MT
Apr. 29	Soleno Therapeutics Gets Breakthrough Therapy Designation for Diazoxide Choline	DJ

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Soleno Therapeutics' Shares Jump After FDA Grants Breakthrough Designation for Prader-Willi Syndrome Treatment	Apr. 29
Soleno Therapeutics, Inc. Receives Breakthrough Therapy Designation from U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome	Apr. 29
Soleno Therapeutics Insider Sold Shares Worth $784,645, According to a Recent SEC Filing	Apr. 04
Soleno Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 06
Soleno Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 06
Soleno Therapeutics Names Meredith Manning as Chief Commercial Officer	Jan. 24
Soleno Therapeutics Strengthens Leadership Team with Key Appointments	Jan. 24
Soleno Therapeutics Files Mixed Shelf	Jan. 03
Soleno Therapeutics Insider Sold Shares Worth $1,412,431, According to a Recent SEC Filing	Dec. 15
Soleno Therapeutics Insider Sold Shares Worth $1,182,828, According to a Recent SEC Filing	Dec. 14
Soleno Therapeutics Insider Sold Shares Worth $222,177, According to a Recent SEC Filing	Dec. 01
Soleno Therapeutics Insider Sold Shares Worth $1,471,049, According to a Recent SEC Filing	Dec. 01
Soleno Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 08
Soleno Therapeutics Announces Peer-Reviewed Publication of Results from Long-Term Open Label Study of DCCR in Prader-Willi Syndrome	Nov. 06
Sector Update: Health Care Stocks Lean Lower Pre-Bell Tuesday	23-10-03
Soleno Therapeutics Closes $69 Million Public Stock Offering	23-10-02
Sector Update: Health Care Stocks Lower Late Tuesday Afternoon	23-09-26
Wall St slides over 1% as Treasury yields hover at 16-year peaks	23-09-26
Top Midday Gainers	23-09-26
Sector Update: Health Care Stocks Declining in Afternoon Trading	23-09-26

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Soleno Therapeutics, Inc.

Equities

SLNO

US8342033094

Other languages

Filters